Skip to content
Search

Latest Stories

Labour sweeps to power, Wes Streeting MP appointed as new health secretary

Labour sweeps to power, Wes Streeting MP appointed as new health secretary

Pharmacies bodies are pleased with Wes Streeting’s acknowledgment of the critical pharmacy funding pressures and his plans for primary care reform

Wes Streeting MP has been appointed Secretary of State for Health and Social Care in the new Labour Government.

The Ilford North MP will now take on the critical role of overseeing the National Health Service (NHS) and implementing Labour's ambitious health agenda.


At the core of the Labour Party’s healthcare reform manifesto is enhancing accessibility to primary and community healthcare.  This involves implementing a ‘Community Pharmacist Prescribing Service,’ to empower pharmacists with independent prescribing rights where clinically suitable.

This initiative aims to alleviate the strain on GP practices and enhance service accessibility.

Additionally, the manifesto proposes piloting Neighbourhood Health Centres, to integrate various healthcare services —such as family doctors, district nurses, and mental health specialists under one roof.

Streeting has recognised the pressing funding challenges faced by pharmacies and shown support for the sector during his campaign.

Commenting on Streeting’s appointment as new Health and Social Care Secretary, Community Pharmacy England (CPE) Chief Executive, Janet Morrison, said: “We would like to welcome the new Secretary of State to his role.

“We worked with Wes and his policy advisors whilst they were in Opposition, and have been encouraged by his recognition of the critical pharmacy funding pressures and support for the sector on the campaign trail.”

CPE is looking forward to “further strengthening Wes’ connection with community pharmacy and to working constructively with him and his colleagues to secure a sustainable future for community pharmacy that also supports the new Government’s health ambitions.”

She added that early discussions with the new government will be aimed at ensuring the future of this critical local healthcare network including finalizing negotiations for the 2024/25 Community Pharmacy Contractual Framework (CPCF) and exploring Labour’s interest in developing a community pharmacy prescribing service.

The Company Chemists’ Association (CCA) is supportive of Streeting’s plans for primary care reform, including the establishment of a ‘Community Pharmacist Prescribing Service’.

Malcolm Harrison, Chief Executive of the CCA said: “We congratulate Wes Streeting on his appointment as Secretary of State for Health and Social Care.

“We are encouraged by Mr. Streeting’s plans for primary care reform and welcome further detail on plans to create a ‘Community Pharmacist Prescribing Service’ and the granting of prescribing rights to pharmacists.”

He noted that community pharmacy is “absolutely integral” to realising the Secretary of State’s vision for primary care – whether that’s the return of the ‘family doctor’, embedding a greater focus on prevention in the NHS, or delivering more and more care closer to people’s homes.”

He added that the sector is ready and willing to delivering this vision but this can only be done “if there is adequate funding to ensure that patients can continue to access the medicines they need.”

“Moreover, pharmacies can do so much more to free up GP capacity, particularly through the expansion of Pharmacy First – but this is only possible through additional investment.”

As reported by Sky News, Wes Streeting studied history at Cambridge University, where he actively participated in student politics. He became the president of the National Union of Students in 2008, at the age of 25.

After his time in student politics, he worked for a Labour-affiliated think tank. In 2010, he was elected as a Labour councillor in Redbridge, East London.

Following five years in local politics, Streeting was elected to the House of Commons in 2015, after winning the seat of Ilford North, the area where he had served as a councillor.

Streeting campaigned for the UK to remain in the European Union in 2016 and was re-elected to the Commons with an increased majority in 2017. After Labour's defeat in the 2019 general election, Jeremy Corbyn resigned, and Sir Keir Starmer took over as party leader.

In April 2020, Streeting joined the party's frontbench as shadow exchequer secretary to the Treasury. By the end of the year, he was appointed shadow schools minister, and in May 2021, he was promoted to the shadow cabinet as the shadow secretary of state for child poverty, a role created for him and later abolished.

In November 2021, Streeting was appointed shadow health secretary.

Sir Keir Starmer has become the new Prime Minister following his Labour Party's landslide victory, marking their return to power after over a decade in opposition.

In his inaugural speech outside 10 Downing Street, Starmer said he would lead a “government of service” on a mission of national renewal.

With results declared for all but two seats, Labour secured 412 seats in the 650-seat House of Commons, while the Conservatives obtained 121 seats.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less